This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
adults without diabetes using GLP-1 receptor agonists more than tripled from 2018 to 2022, boosting annual spending from $1.6 (MedPage Today) -- The number of U.S. billion to $5.8 billion, survey data showed. Based on an unweighted sample of nearly.
ObjectiveTo explore the risk factors for cardiotoxicity in patients with gastrointestinal (GI) tumors treated with fluorouracil drugs.MethodsThis study included patients with GI tumors who received fluorouracil at our hospital between January 2018 and April 2022. The demographic and clinical characteristics were collected.
Objective Population-based national data on the trends in expenditures related to coexisting atherosclerotic cardiovascular diseases (ASCVD) and diabetes is scarce. Individuals with diabetes had a 1.5-fold fold higher mean expenditure that those without diabetes. individuals aged ≥ 18 years.
The prognostic value of triglyceride-glucose (TyG) index in general type 2 diabetes mellitus (T2DM) patients is still unclear. Therefore, we aimed to determine the associations between TyG and all-cause/cause-.
Methods Data from the National Health and Nutrition Examination Survey (NHANES) conducted between 2005 and 2018 were analyzed. This study aims to identify the sources of gender disparities in mortality rates and quantify the extent to which these factors mediate the gender differences in all-cause mortality. 1.68] and 1.60 (95%CI:1.43–1.80)
IntroductionThe present study aimed to examine the additive interaction of family medical history of cardiovascular disease (CVD) and self-reported hypertension and diabetes on the diagnosis of CVD among older adults aged 45 years and above in India. The total sample size for the study was 58,734 older adults aged 45 years and above.
Obesity and abnormal lipid metabolism increase the risk of various cardiometabolic diseases, including diabetes, heart disease, and stroke. However, the impact of abdominal obesity (AO) and non-traditional lip.
Excess visceral fat results in a higher risk of insulin resistance, which is the precursor state to diabetes. The relationship between excess weight, a high BMI and the risk of severe insulin resistance and diabetes is clear 4. Relationship of BMI and Risk Of Diabetes. You put their diabetes into remission. Losing 6.5%
The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with.
Generalized linear models with Poisson distribution were used to examine the prevalence and prevalence ratios of self‐reported hypertension, diabetes, high cholesterol, physical inactivity, smoking, and overweight/obesity among Asian subgroups compared with US‐born NHW adults. Participants' mean (±SD) age was 49±0.1
Background:The current AHA stroke prevention guidelines give Class 1 recommendations that patients with AIS and diabetes should receive glucose-lowering agents with cardiovascular benefit to reduce risk of MACE. Patients were identified to have diabetes as derived by the Charlson Comorbidity Index ICD 10 codes E10 through E14.
Methods Data from the National Health and Nutrition Examination Survey (NHANES) 2015–2018 were collected and analyzed. Stratified analysis and interaction tests were carried out according to hypertension, diabetes and age. Hypertension and diabetes interacted with high-risk sleep patterns, but age did not.
A 10 to 15kg weight loss in those who are overweight can reverse diabetes in 57% of patients with diabetes 1. Even in diabetics of normal weight (BMI<27), weight loss can reverse diabetes 2. 2018 Feb 10;391(10120):541-551. Diabetes 70(Supplement 1):1184-P What should you eat to do this?
When compared with placebo, glucagon-like peptide-1 receptor agonists such as once-weekly semaglutide (semaglutide OW T2D) improve cardiovascular outcomes in people with type 2 diabetes (T2D), whereas dipeptidyl peptidase-4 inhibitors (DPP-4is) do not. However, no head-to-head trials of these 2 incretin-based drug classes have been conducted.
Method Retrospective analysis of STEMI patients treated with PCI from April 2018 to April 2021 in Fuyang People’s Hospital. Lasso regression was used to screen the risk factors for the first occurrence of MACE in patients, and multifactorial logistic regression analysis was used to construct a prediction model.
Data from 36 970 consecutive PCI cases performed between 2014 and 2018 were analysed. Those who developed renal impairment were more comorbid, with higher rates of diabetes (22% vs 38% vs 38%, p<0.001), peripheral vascular disease (3.4% 96.3% (n=35 611) of patients did not develop NRI.
Diabetes was present in 28% and multivessel disease in 51%. BACKGROUND:The appropriate use criteria for revascularization of stable ischemic heart disease have not been evaluated using randomized data. Differences in the primary clinical outcome were similarly examined.RESULTS:The mean age was 63 years, 81% were male, and 71% were White.
Methods Cross-sectional study conducted between 2018 and 2021 in Lausanne, Switzerland. Prevalence, awareness, treatment and control rates of hypertension, dyslipidaemia and diabetes were compared between the periods before (N=2416, 45.2% For diabetes, prevalence did not change but awareness increased 5.76 (95% CI 1.23
We present the cumulative percutaneous coronary intervention (PCI) data of all comers (stable angina and acute coronary syndromes [ACS]) who presented to Hadi Clinic between January 2018 and December 2020. A total of 567 patients underwent coronary catheterisation for the three-year period between January 2018 and December 2020.
Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular risk factors: heart failure, diabetes, atrial fibrillation, dyslipidemia and hypertension.
We calculated total patients with potentially undiagnosed hypertension and compared patients flagged for undiagnosed hypertension to those with diagnosed hypertension and to the full patient panel across individual characteristics, clinical and health system factors (eg, clinic of care), and timing.
The purpose of this study is to clarify the incidence rate of IHOS among hospitalized patients and to investigate the risk factors associated with IHOS.Methods:Patients consecutively admitted to the Nippon Medical School hospital between April 2018 and March 2023 were assessed.
17.4]) and was also more likely to have diabetes mellitus, hyperlipidemia, chronic lung disease, chronic kidney disease, chronic liver disease, BMI ≥ 25, anemia, metastatic cancer, and atrial fibrillation. The overall study population was compared to the general population, non-hemophilia. The hemophilia cohort was slightly older (63.2[16.8]
Here, we aimed to develop a nomogram model utilizing multimodal data for the risk stratification of AF recurrence following catheter ablation in individuals diagnosed with PFO and new-onset PAF.Methods:Patients with PFO and PAF who underwent catheter ablation at our hospital from January 2018 to June 2020 were consecutively enrolled.
Therefore, we examined the temporal trends in cardiovascular conditions among Chinese, Filipino, and Asian Indian adults living in the U.S.Methods:We conducted a cross-sectional analysis using the 2004-2018 National Health Interview Survey.
Between 2016 and 2018, 3285 MESA participants from 6 field centers underwent comprehensive speckle-tracking echocardiography with passive leg raise maneuver, Kansas City Cardiomyopathy Questionnaire, 6-minute walk test, arterial stiffness assessment, and proteomics (including NT-proBNP [N-terminal pro-B-type natriuretic peptide]).Results:Median
We aim to study if patients with severe cervical myalgias and FHP have an increased risk of posterior circulation stroke.Methods:We identified all adult patients with posterior circulation stroke and diagnosis of cervical myalgia at Loyola University Medical Center from January 2018 to January 2023. The average C2 tilt of cases was 22.9
METHODS:The J-HOP study enrolled outpatients with ≥1 cardiovascular risk factor between 2005 and 2012, with follow-up until March 2015 and extended follow-up from December 2017 to May 2018. Findings were similar in the subgroup of high-risk patients (those with diabetes or stroke history).CONCLUSIONS:These
In the United States, syphilis rates have been increasing at an alarming rate since 2000, and between 2018-2022 cases increased by nearly 80%. Introduction:Syphilis is associated with increased risk of cerebrovascular disease and acute stroke; stroke may even be the initial clinical manifestation of syphilis (Images 1 and 2).
This study compares outcomes of these treatments and evaluates the correlation between clinical features and medical history with 30-day outcome.Methods:Patients with VBAS were identified from the 2017-2018 National Inpatient Sample (NIS). Hypertension (HTN, 85.4%) and diabetes (DM, 18.9%) were prevalent. Mean age was 69.45
Insulin resistance is a precursor condition to metabolic syndrome and type 2 diabetes, both major drivers of heart disease. 2018 Apr 10;90(15):e1298-e1305. Poor Sleep Is A Major Risk Factor For Insulin Resistance. Insulin resistance is a significant driver of cardiovascular risk. Lancet Healthy Longev. 2023 Jul;4(7):e345-e353.
This study examined the relationship between marijuana use, ASCVD risk factors, and cardiometabolic risk profiles.METHODS:US adults (18–59 years) without cardiovascular disease were identified from the National Health And Nutrition Examination Survey (2005–2018) based on self-reported marijuana use. female; 13% non-Hispanic Black), 26.6%
Written by Willy Frick A man in his 50s with a history of hypertension, dyslipidemia, type 2 diabetes mellitus, and prior inferior OMI status post DES to his proximal RCA 3 years prior presented to the emergency department at around 3 AM complaining of chest pain onset around 9 PM the evening prior.
Repeat ECGs make difficult decisions easier. -- Comment by K EN G RAUER, MD ( 12/29/2018 ): -- Superb case by Dr. Pendell Meyers, which highlights recognition of subtle acute findings. Although I arrived at the same conclusion as Drs.
LDL cholesterol, when measured in the context of diabetes, metabolic syndrome or insulin resistance, is not an accurate reflection of the number of apoB particles in circulation. 4 Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites. Eur Heart J. 2009 Aug;58(8):1887-92.
What do you think would happen to someone's blood pressure, LDL cholesterol, or blood glucose if you were to evaluate what happens after you stop their blood pressure, cholesterol-lowering, or diabetes medication? 2018 Jan;102(1):183-197. Diabetes Obes Metab. The exact same thing. But we know one thing for certain.
This patient with a history diabetes was found with a GCS of 4. Comment by K EN G RAUER, MD ( 12/11/2018 ): = I love this case — because it brings home 3 of my favorite teaching points about electrolyte disorders and ECG interpretation. There just aren’t that many clinical conditions that cause hyperkalemia.
Case submitted and written by Mazen El-Baba MD, with edits from Jesse McLaren and edits/comments by Smith and Grauer A 90-year old with a past medical history of atrial fibrillation, type-2 diabetes, hypertension, dyslipidemia, presented with acute onset chest/epigastric pain, nausea, and vomiting. BP was 110 and oxygen saturation was normal.
In the US, over 45% of the population has either diabetes or pre-diabetes 1. The absolute majority of those with diabetes have type 2 diabetes, which is usually associated with excess visceral fat and poor cardiometabolic health. Because a diagnosis of diabetes is very likely to shorten your life. Pre-Diabetes.
edits by Meyers A woman in her 60s with a history of chronic atrial fibrillation on Eliquis, ESRD on hemodialysis, type-II diabetes mellitus, prior CVA, hypertension, and hyperlipidemia presented to the emergency department with multiple complaints after missing dialysis. Case written by Brandon Friedman M.D.,
BACKGROUND:The purpose of this study is to examine the association between race and ethnicity and ischemic stroke severity in the United States.METHODS:We performed an analysis of adult hospital discharges in the National Inpatient Sample from 2018 to 2021 with a primary discharge diagnosis of ischemic stroke.
The patient was in his 50s with history of hypertension, diabetes, seizure disorder, and smoking, but no known coronary artery disease. My Comment by K EN G RAUER, MD ( 10/6 /2018 ): = Superb case presented by Dr. Meyers! I limit my comments to reinforcing several important concepts emphasized by him.
The 14 Factors Include: Hearing Loss High LDL cholesterol Less Education Traumatic Brain Injury Depression Social Isolation Hypertension Obesity Smoking Excess Alcohol Diabetes Physical Inactivity Air Pollution Visual Loss Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission When You Intervene Matters.
BackgroundMeta‐analyses of large clinical trials investigating SGLT2 (sodium‐glucose cotransporter‐2) inhibitors have suggested their protective effects against atrial fibrillation in patients with type 2 diabetes. An active‐comparator, new‐user design was used, and the 2 groups of patients were matched using propensity scores.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content